Skip to main content

Malignant Testicular Sex Cord-Stromal Tumor clinical trials at UC Health
1 in progress, 1 open to new patients

  • Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

    open to eligible people ages 18 years and up

    This clinical trial studies nivolumab and ipilimumab in treating patients with rare tumors. Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread.

    at UC IrvineUCSDUC Davis